Conference Coverage

VIDEO: Novel three-shot immunotherapy regimen


 

AT 2015 AAAAI ANNUAL MEETING

References

HOUSTON– Dr. Amber M. Patterson of Nationwide Children’s Hospital and Research Institute in Columbus, Ohio, provides the lowdown on intralymphatic immunotherapy, in which a three-injection protocol of ultrasound-guided lymph node injections spaced 4 weeks apart is being investigated as a treatment for grass pollen-induced rhinoconjunctivitis in adolescents. It’s an attractive alternative to the conventional 3-year regimen of weekly, then monthly subcutaneous immunotherapy injections.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

bjancin@frontlinemedcom.com

Recommended Reading

Respiratory harm reversal seen in asthmatic smokers on e-cigarettes
MDedge Family Medicine
Reslizumab aces pivotal trials in asthma with eosinophilia
MDedge Family Medicine
Allergists must standardize penicillin allergy patient testing, advice, and labeling
MDedge Family Medicine
Annual recurrence rate of anaphylaxis in kids is nearly 30%
MDedge Family Medicine
Consider off-label immunosuppressants for refractory urticaria
MDedge Family Medicine
Epinephrine use for anaphylaxis in schools: First national survey
MDedge Family Medicine
Beware common management pitfalls in severe refractory pediatric AD
MDedge Family Medicine
SLIT: Guidelines in progress and practical concerns
MDedge Family Medicine
When to use SLIT and SCID in atopic dermatitis
MDedge Family Medicine
VIDEO: Penicillin skin testing improves inpatient antibiotic stewardship
MDedge Family Medicine